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ABSTRACT 
Recurrent respiratory symptoms are common in infants but the paucity of lung function 
tests suitable for routine use in infants is a widely acknowledged clinical problem. In this 
study we evaluated tidal breathing variability (expiratory variability index, EVI) measured 
at home during sleep using impedance pneumography (IP) as a marker of lower airway 
obstruction in 36 infants (mean age 12.8 [range 6-23] months) with recurrent respiratory 
symptoms. Lowered EVI was associated with lower lung function (VmaxFRC), higher 
asthma risk, and obstructive symptoms, but not with nasal congestion. EVI measured using 
IP is a potential technique for lung function testing in infants. 
Analysis of tidal breathing flow-volume (TBFV) curves is a convenient method to assess lung 
function in infants. We have shown that impedance pneumography (IP) is a valid method to assess 
overnight TBFV profiles in young children [1] and infants [2] and that certain specific curve shapes 
are related to symptom presentation and asthma risk [3]. We have also shown that the reduced 
variability of TBFV curves may be an indicator of airway obstruction in children [4–6]. However, in 
infants, it is unknown whether overnight TBFV variability is associated with respiratory symptoms 
or asthma risk. 
TBFV variability has been expressed in several ways [4, 5, 7–10]. The recently introduced 
expiratory variability index (EVI) is derived by calculating correlations between expiratory TBFV 
curves, with low EVI indicating reduced variability of the curve shapes [6]. 
In this study, we hypothesised that TBFV variability, expressed as EVI, would be associated with 
wheeze and asthma risk in infants with recurrent respiratory symptoms.  
The patient sample was described in detail earlier [3]. Briefly, between January 2014 and May 
2017 we recruited 43 infants referred to the Department of Allergy, Helsinki University Hospital, for 
infant lung function testing because of recurrent respiratory symptoms such as wheeze, cough, 
and/or laborious breathing. 
Children were classified by asthma risk by using loose criteria of the modified Asthma Predictive 
Index (mAPI): Children with a history of multiple episodes of wheeze (at least 2) and who fulfilled 
one of the major criteria (parental history of asthma, atopic dermatitis, sensitization to respiratory 
allergens), were considered to have a high risk of asthma. Children who did not have a history of 
wheeze or did not fulfil any of the major criteria above were considered to have low risk. Infants 
who fell between the criteria of high and low risk were considered to have an intermediate risk. 
Children with current respiratory infection were excluded. 
Lung function was determined by measuring the maximal flow at functional residual capacity 
(VmaxFRC) using rapid thoracic compression (Babybody Masterscreen, Jaeger Ltd., Germany) 
under sedation, and expressed as z scores, adjusting for weight, length, and/or sex [11]. Fractional 
exhaled nitric oxide (FeNO) was measured with the tidal online technique [12]. In a subgroup of 
infants (n=14), airway hyperresponsiveness (AHR) to methacholine was assessed as described 
earlier [13] and expressed as the provocative dose causing a reduction of 40% in VmaxFRC 
(PD40VmaxFRC).  After lung function tests, an IP device (university-developed prototype [14]) was 
installed on the subjects for overnight recording at home. The study was approved by the 
institutional paediatric ethics committee of Helsinki University Central Hospital (approval no. 53/13/ 
03/03/2012). All parents gave written informed consent.  
The previously recorded raw impedance signals were re-processed using commercial software 
(Ventica Analytics 2.1.0, Revenio Research Ltd., Finland) for the expiratory variability index (EVI). 
EVI is derived by calculating Pearson correlations between all partial (15-45 % of exhaled volume 
[5]), averaged (5-minute window) TBFV curves recorded from the duration of the night’s sleep 
resulting in a large number of correlation values. The output is given as EVI=[log10[IQR(r)]+2]*10, 
where IQR(r) is the inter-quartile range of the correlations. EVI thus measures the variability 
(dissimilarity) between TBFV curves compared to each other from all parts of the night, low EVI 
indicating low variability. 
Parametric tests (Student’s t test, ANOVA linear trend test) were used for comparing EVI between 
categories if EVI was normally distributed in each category (Shapiro-Wilks test p value above 0.05). 
Otherwise non-parametric test (Mann-Whitney U test) was used (only for nasal congestion and 
atopic eczema). Association of EVI with continuous variables (VmaxFRC, PD40VmaxFRC, FeNO) 
was assessed by Pearson correlation. No adjustments for multiple comparisons were made. 
Overnight IP recordings at home were attempted on 43 infants of which 7 were rejected by the 
processing software because of bad electrode contact or malfunctioning of the prototype recorders. 
In 36 children IP measurements were successful allowing the calculation of EVI result. These 
children were 12.8 (5.1, 6.0-23.0) (mean, SD, range) months old, 20 (56 %) of them had atopic 
eczema, 9 (25 %) positive skin prick test finding and they had had 1.7 (1.5) past wheeze episodes. 
 
Figure 1. Expiratory variability index (EVI) compared with A) asthma risk groups, B) main 
symptom, and C) lung function. Circles and whiskers denote, respectively, mean, and its 95% 
confidence interval. Dots represent results of individual patients. Two patients did not have 
VmaxFRC results available. 
EVI was different between asthma risk categories (ANOVA linear trend test p=0.022, figure 1A) 
being lowest in the high asthma risk children. Children with prolonged expiration (n=14) or wheeze 
as the main symptom had lower EVI than those with only cough (n=22) (Student’s t test p=0.044, 
figure 1B). EVI showed positive correlation with VmaxFRC (Pearson correlation r=0.52, p=0.002, 
figure 1C). 
EVI values from children with nasal congestion (n=10) were not statistically different from those 
without congestion (Mann-Whitney U test p=0.50, figure 1C). This is in line with a recent finding in 
older children [6]. EVI was not correlated with age (Pearson correlation r=-0.06). 
In overnight recordings, EVI was not significantly associated with AHR (Pearson correlation r=0.11, 
p=0.70), nor with atopic eczema (Mann-Whitney U test p=0.40), prick test (Student’s t test p=0.49) 
or FeNO (Pearson correlation r=0.21, p=0.24). 
In our previous study, we demonstrated that certain features of the shape of the expiratory flow-
volume curve are associated with asthma risk and lung function in infants with respiratory 
symptoms [3]. In this study, we focused instead only on the variability of the curve shapes, 
expressed as EVI. Although the within-subject variation was large, we found EVI to associate with 
asthma risk, main symptom and lung function. The associations were only modest which may be 
attributed to small sample size and the low specificity and heterogeneity of the outcomes for 
asthma. 
In this observational study, the results indicate reduced TBFV variability in infants with wheeze, 
which agrees with studies in in adults with asthma [7] and COPD [8], children with asthma [4, 9] 
and infants with bronchopulmonary dysplasia [10]. This reduced variation in TBFV pattern which 
has been attributed to reduced adaptability of the respiratory system during mechanical loading by 
airway obstruction [7] should be distinguished from the other phenomenon of increased variation 
in respiratory impedance or diurnal peak flow commonly known as characteristics of asthma [15].  
EVI did not show association with AHR to methacholine. We speculate that decreased TBFV 
variability as expressed by EVI, is more closely related to reduced lung function and adaptive 
mechanisms of tidal breathing than to AHR [3]. VmaxFRC as a lung function measure has a wide 
intersubject variability in infants which explains the modest association with EVI. Moreover, the 
mechanisms of reduced VmaxFRC vary between infants with respiratory symptoms. Depending 
on the mechanical resistive or elastic loading, neural and mechanical adaptive changes in 
breathing pattern may change and affect EVI differently [16]. It has been shown that sleep stages 
are a major contributor to normal TBFV curve changes which constitute normal (high) EVI [17]. 
Cough as the main symptom may have heterogeneous aetiology and it is an unsure sign of airway 
obstruction. This agrees with our finding of reduced EVI being more common in infants with 
wheeze as the main symptom.  We acknowledge that due to the lack of a healthy control group 
and longitudinal data we are unable to estimate the proportion of abnormal EVI results in different 
patient groups or assess the specificity of EVI to estimate asthma risk in infants with recurrent 
respiratory symptoms. Furthermore, in this study, we did not estimate the interactions between 
sleep architecture and EVI, which need further studies. 
In conclusion, the results suggest that variability of nocturnal tidal breathing, as quantified by the 
EVI parameter measured using the IP technique, is associated with asthma risk, symptoms and 
lung function in infants with recurrent respiratory symptoms. Provided that the findings are 
repeated in larger cohorts of infants, this technique may prove to be a useful, easy tool for objective 
assessment of respiratory symptoms in this age group where lung function testing is difficult. 
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